| 영문 | edema | 한글 | 부종 |
|---|---|---|---|
| 설명 | 조직내에 림프액이나 조직의 삼출물 등의 액체가 저류되어서 과잉 존재하는 상태를 말한다. 이런 현상은 생기는 부위에 따라 피하부종, 폐부종, 복수라 하며, 발생 기전에 따라 분류하면 울혈성 부종, 염증성 부종, 혈관운동성 부종, 기아성 부종, 콩팥탓 부종 등으로 분류된다. 울혈성 부종은 기능성 부종이라고도 하며, 정맥이나 림프관의 협착, 폐쇄로 인하여 정상적인 흐름이 방해받았을 때에 발생하는 것이다. 염증성 부종은 염증성 변화로 인해서 혈관의 투과성이 항진되어 혈관속에 있는 수분이 많이 조직으로 빠져 나가서 생기는 부종이고, 혈관운동성 부종은 혈관운동신경 마비로 유발되며, 기아성 부종은 만성적으로 영양이 부족한 경우에 생기는 부종이다. 콩팥탓 부종은 콩팥병이 있는 경우에 소변으로 영양분이 빠져나가는 경우에 유발된다. 부종은 생기는 부위에 따라 다소 차이가 있을지라도 발생기전에서는 서로 밀접한 관련을 맺고 있으므로 근본적인 원인을 찾아내어 치료를 시작하는 것이 바람직하다. |
||
| 영문 | IDDM(Insulin-Dependent Diabetes Mellitus) | 한글 | 인슐린의존당뇨병 |
|---|---|---|---|
| 설명 | IDDM은 당뇨병의 치료에 반드시 인슐린이 필요한 경우를 말한다. 주로 원인이 이자에 있는 인슐린을 분비하는 세포의 파괴이며 이로 인해서 당뇨병의 치료제로 쓰이는 인슐린의 분비를 촉진하는 약물이 이 IDDM에서는 쓰일 수가 없고 오직 인슐린만이 치료제로 쓸 수가 있다. 전형적인 인슐린 의존형 당뇨병은 소아에서 흔히 발생하고 인슐린 분비세포의 파괴에 의해서 인슐린 분비능은 거의 없다. |
||
| HPE | hepatic portoenterostomy; high-permeability edema; history and physical examination; holoprosencepha... |
|---|---|
| TD | tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus... |
| EF | Edema Factor |
| HACE | High Altitude Cerebral Edema |
| HAPE | High Altitude Pulmonary Edema |
| BE | Brain edema |
|---|---|
| CSME | Clinically significant macular edema |
| CME | Cystoid macular edema |
| EPH | Edema Proteinuria Hypertension |
| HANE | Hereditary Angio Neurotic Edema |
| edema | <clinical sign> The presence of abnormally large amounts of fluid in the intercellular tissue spaces of the body, usually applied to demonstrable accumulation of excessive fluid in the subcutaneous tissues. Oedema may be localised, due to venous or lymphatic obstruction or to increased vascular permeability or it may be systemic due to heart failure or renal disease. Collections of oedema fluid are designated according to the site, for example ascites (peritoneal cavity), hydrothorax (pleural cavity) and hydropericardium (pericardial sac). Massive generalised oedema is called anasarca. Origin: Gr. Oide ma = swelling (18 Nov 1997) |
|---|---|
| edema, cardiac | A manifestation of congestive heart failure caused by increased venous and capillary pressures and often associated with the retention of sodium by the kidneys. (12 Dec 1998) |
| aid to families with dependent children | Financial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the social security act, title IV, in the u.s. (12 Dec 1998) |
| androgen-dependent secretory protease | <enzyme> Glycoprotein from dog prostate; hydrolyzes arginine and lysine-containing amide and ester protease substrates Registry number: EC 3.4.99.- Synonym: ads-protease (26 Jun 1999) |
| antibody-dependent cell cytotoxicity | The phenomenon of antibody-mediated target cell destruction by non-sensitised effector cells. The identity of the target cell varies, but it must possess surface IgG whose fc portion is intact. The effector cell is a "killer" cell possessing fc receptors. It may be a lymphocyte lacking conventional b- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. (12 Dec 1998) |
| antibody-dependent enhancement | Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by fc receptors (receptors, fc) or by complement receptors (receptors, complement). Either the virus is complexed with antiviral IgG and binds to fc receptors, or virus is coated with antiviral IgM and binds to complement receptors. (12 Dec 1998) |
| aromatic NADH-dependent nitroreductase | <enzyme> See also record for 1-nitroreductase; type I nitroreductase is not inhibited by oxygen Registry number: EC 1.- Synonym: nitrofuran reductase, nitrofurazone reductase, type I nitroreductases, NADH-dependent nitro reductase, nitrofurantoin reductase, p-dinitrobenzene reductase, benznidazole nitroreductase, nifurtimox nitroreductase, oxygen-insensitive NADPH nitroreductase, nitrobenzene nitroreductase (26 Jun 1999) |
| aspartic acid 2-oxoglutarate-dependent dioxygenase | <enzyme> Hydroxylates one aspartic acid residue in the first egf-like unit of factor ix Registry number: EC 1.14.11.- Synonym: aspartate 2-oxoglutarate dioxygenase, asp-2-og-dioxygenase, aspartyl beta-hydroxylase, aspartyl (asparaginyl) beta-hydroxylase (26 Jun 1999) |
| ATP dependent 26S protease | <enzyme> Degrades proteins conjugated to ubiquitin; composed of cf-1,cf-2, and cf-3; cf-2 (also known as 240-kD proteasome inhibitor) is identical to aminolevulinic acid dehydratase Registry number: EC 3.4.99.- Synonym: 26s protease, 26 s proteasome complex, 26s proteasome (26 Jun 1999) |
| ATP-dependent DNA strand transferase | <enzyme> From human cell nuclei; catalyses strand exchange between homologous DNA sequences; magnesium dependent, requires ATP hydrolysis Registry number: EC 2.7.7.- Synonym: ATP-dep-DNA-str trnsfase (26 Jun 1999) |
| ATP-ubiquitin-dependent proteinase | <enzyme> A component of the cytosolic ubiquitin-dependent proteolysis system Registry number: EC 3.4.- Synonym: ucden (26 Jun 1999) |
| autophosphorylation-dependent multifunctional protein kinase | <enzyme> A camp/ca(2+)-independent protein kinase; phosphorylates and activates phosphorylase b kinase; phosphorylates and inactivates glycogen synthase Registry number: EC 2.7.1.- Synonym: auto-kinase (26 Jun 1999) |
| calcium-calmodulin-dependent phosphodiesterase | <enzyme> Hydrolyzes both cgmp and camp; induced during mitogenesis Registry number: EC 3.1.4.- Synonym: ca-cam-phosphodiesterase, calmodulin-dependent cgmp phosphodiesterase (26 Jun 1999) |
| calcium-calmodulin dependent protein kinase | <enzyme> A calmodulin-dependent enzyme that catalyses the phosphorylation of proteins. This enzyme is also sometimes dependent on calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins. Registry number: EC 2.7.10.- (12 Dec 1998) |
| calcium-dependent protein kinase | <enzyme> Mw 51,000; requires ca; not stimulated by calmodulin, phospholipids or diacylglycerol; phosphorylates casein and histones forming primarily phosphoserine and phosphothreonine, respectively Registry number: EC 2.7.1.- Synonym: paramecium ca-dependent protein kinase (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|